KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogenomics (NEO) Cost of Revenue (2016 - 2026)

Neogenomics filings provide 17 years of Cost of Revenue readings, the most recent being $105.8 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 366.46% to $105.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $260.7 million, a 49.46% decrease, with the full-year FY2025 number at $92.0 million, down 75.16% from a year prior.
  • Cost of Revenue hit $105.8 million in Q1 2026 for Neogenomics, up from $23.4 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $308.2 million in Q4 2024 to a low of -$188.2 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $24.1 million (2025), compared with a mean of $55.0 million.
  • Biggest five-year swings in Cost of Revenue: plummeted 1198.08% in 2023 and later soared 458.28% in 2024.
  • Neogenomics' Cost of Revenue stood at $17.1 million in 2022, then plummeted by 1198.08% to -$188.2 million in 2023, then skyrocketed by 263.71% to $308.2 million in 2024, then plummeted by 92.39% to $23.4 million in 2025, then surged by 351.34% to $105.8 million in 2026.
  • The last three reported values for Cost of Revenue were $105.8 million (Q1 2026), $23.4 million (Q4 2025), and $107.4 million (Q3 2025) per Business Quant data.